EGFR and glioblastoma: Furthermore, molecular subtypes of GBM exhibit changes in genes that include epidermal growth factor receptor (EGFR), Neurofibromin 1 (NF1), and platelet‐derived growth factor receptor A (PDGFRA), which affect various metabolic pathways.